封面
市場調查報告書
商品編碼
1386586

基於 NGS 的 RNA 定序市場報告:2030 年趨勢、預測與競爭分析

NGS-Based RNA-Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

基於 NGS 的 RNA 定序趨勢和預測

到 2030 年,全球基於 NGS 的 RNA 定序市場預計將達到 84 億美元,2024 年至 2030 年的年複合成長率為 17.6%。這個市場的主要促進因素是對個人化醫療的需求不斷成長以及人們對 NGS-RNA 定序優勢的認知不斷提高。全球基於NGS的RNA定序市場前景廣闊,在研究/學術、醫院/診所和製藥/生技市場中蘊藏著商機。

基於NGS的RNA定序市場洞察

Lucintel 預測,由於基因發現、差異基因表現分析和轉錄組分析的需求不斷增加,表達分析仍將是最大的領域。

由於對個人化醫療的高需求、強大的醫療基礎設施以及該地區主要參與者的存在,北美仍將是最大的地區。

本報告回答了 11 個關鍵問題:

  • Q.1. 細分市場中最有前途和高成長的機會是什麼?
  • Q.2.哪個細分市場將以更快的速度成長?為什麼?
  • Q.3.您認為哪些地區未來會出現更快的成長?為什麼?
  • Q.4. 影響市場動態的主要因素有哪些?市場的主要挑戰和商業風險是什麼?
  • Q.5. 這個市場的商業風險和競爭威脅是什麼?
  • Q.6.這個市場有哪些新趨勢?為什麼?
  • Q.7.市場客戶需求有何改變?
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?主要企業採取哪些策略配合措施來發展業務?
  • Q.10. 該市場上的競爭產品有哪些?由於材料或產品替代而導致市場佔有率下降的威脅有多大?
  • Q.11.過去年度發生了哪些併購事件,對產業產生了哪些影響?

目錄

第1章 執行摘要

第2章 全球基於NGS的RNA定序市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球基於NGS的RNA定序市場趨勢(2018-2023)與預測(2024-2030)
  • 按產品類型分類的全球基於 NGS 的 RNA 定序市場
    • 樣品製備產品
    • RNA定序平台與消耗品
    • RNA定序服務
    • 資料分析、儲存和管理
  • 按技術分類的全球基於 NGS 的 RNA 定序市場
    • 合成定序
    • 離子半導體序列
    • 單分子即時定序
    • 奈米孔定序
  • 全球基於NGS的RNA定序市場(按應用)
    • 表達譜分析
    • 小RNA定序
    • 從頭轉錄組組裝
    • 變異調用和轉錄組表觀磊晶
    • 其他
  • 全球基於 NGS 的 RNA 定序市場(按最終用途)
    • 研究和學術
    • 醫院和診所
    • 製藥和生物技術
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球基於NGS的RNA定序市場(按地區)
  • 北美基於NGS的RNA定序市場
  • 歐洲基於NGS的RNA定序市場
  • 亞太地區基於NGS的RNA定序市場
  • 其他地區則基於NGS的RNA定序市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球基於 NGS 的 RNA 定序市場成長機會
    • 全球基於 NGS 的 RNA 定序市場成長機會(按技術)
    • 全球基於 NGS 的 RNA 定序市場成長機會(按應用)
    • 全球基於 NGS 的 RNA 定序市場成長機會(按最終用途)
    • 全球基於NGS的RNA定序市場成長機會(按地區)
  • 全球基於NGS的RNA定序市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球 NGS RNA 定序市場的產能
    • 全球基於NGS的RNA測序市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Illumina
  • Thermo Fischer Scientific
  • Oxford Nanopore Technologies
  • Agilent Technologies
  • BGI
簡介目錄

NGS-Based RNA-Sequencing Trends and Forecast

The future of the global NGS-based RNA-sequencing market looks promising with opportunities in the research and academia, hospital and clinic, and pharmaceutical & biotechnology markets. The global NGS-based RNA-sequencing market is expected to reach an estimated $8.4 billion by 2030 with a CAGR of 17.6% from 2024 to 2030. The major drivers for this market are escalating demand for personalized medicine and rising awareness of the benefits of NGS-RNA-sequencing.

A more than 150-page report is developed to help in your business decisions.

NGS-Based RNA-Sequencing by Segment

The study includes a forecast for the global NGS-based RNA-sequencing by product type, technology, application, end use, and region.

NGS-Based RNA-Sequencing Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Sample Preparation Products
  • RNA-sequencing Platforms and Consumables
  • RNA-sequencing Services
  • Data Analysis, Storage & Management

NGS-Based RNA-Sequencing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing

NGS-Based RNA-Sequencing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Expression Profiling Analysis
  • Small RNA-Sequencing
  • De Novo Transcriptome Assembly
  • Variant Calling & Transcriptome Epigenetics
  • Others

NGS-Based RNA-Sequencing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Research and Academia
  • Hospitals and Clinics
  • Pharmaceutical & Biotechnology
  • Others

NGS-Based RNA-Sequencing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of NGS-Based RNA-Sequencing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies NGS-based RNA-sequencing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the NGS-based RNA-sequencing companies profiled in this report include-

  • Illumina
  • Thermo Fischer Scientific
  • Oxford Nanopore Technologies
  • Agilent Technologies
  • BGI

NGS-Based RNA-Sequencing Market Insights

Lucintel forecasts that expression profiling analysis will remain the largest region due to its increasing demand in gene discovery, differential gene expression analysis, and transcriptome profiling.

North America will remain the largest region due to high demand for personalized medicine, existence of robust healthcare infrastructure, and presence of key players in the region.

Features of the Global NGS-Based RNA-Sequencing Market

Market Size Estimates: Ngs-based RNA-sequencing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ngs-based RNA-sequencing market size by various segments, such as by product type, technology, application, end use, and region in terms of ($B).

Regional Analysis: Ngs-based RNA-sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the NGS-based RNA-sequencing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the NGS-based RNA-sequencing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the NGS-based RNA-sequencing market size?

Answer: The global NGS-based RNA-sequencing market is expected to reach an estimated $8.4 billion by 2030.

Q.2 What is the growth forecast for NGS-based RNA-sequencing market?

Answer: The global NGS-based RNA-sequencing market is expected to grow with a CAGR of 17.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the NGS-based RNA-sequencing market?

Answer: The major drivers for this market are escalating demand for personalized medicine and rising awareness of the benefits of NGS-RNA-sequencing.

Q4. What are the major segments for NGS-based RNA-sequencing market?

Answer: The future of the NGS-based RNA-sequencing market looks promising with opportunities in the research and academia, hospitals and clinics, and pharmaceutical & biotechnology markets.

Q5. Who are the key NGS-based RNA-sequencing market companies?

Answer: Some of the key NGS-based RNA-sequencing companies are as follows:

  • Illumina
  • Thermo Fischer Scientific
  • Oxford Nanopore Technologies
  • Agilent Technologies
  • BGI

Q6. Which NGS-based RNA-sequencing market segment will be the largest in future?

Answer: Lucintel forecasts that expression profiling analysis will remain the largest region due to its increasing demand in gene discovery, differential gene expression analysis, and transcriptome profiling.

Q7. In NGS-based RNA-sequencing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to high demand for personalized medicine, existence of robust healthcare infrastructure, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the NGS-based RNA-sequencing market by product type (sample preparation products, RNA-sequencing platforms and consumables, RNA-sequencing services, and data analysis, storage & management), technology (sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing), application (expression profiling analysis, small RNA-sequencing, de novo transcriptome assembly, variant calling & transcriptome epigenetics, and others), end use (research and academia, hospitals and clinics, pharmaceutical & biotechnology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global NGS-Based RNA-Sequencing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global NGS-Based RNA-Sequencing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global NGS-Based RNA-Sequencing Market by Product Type
    • 3.3.1: Sample Preparation Products
    • 3.3.2: RNA-sequencing Platforms and Consumables
    • 3.3.3: RNA-sequencing Services
    • 3.3.4: Data Analysis, Storage & Management
  • 3.4: Global NGS-Based RNA-Sequencing Market by Technology
    • 3.4.1: Sequencing by Synthesis
    • 3.4.2: Ion Semiconductor Sequencing
    • 3.4.3: Single-molecule Real-time Sequencing
    • 3.4.4: Nanopore Sequencing
  • 3.5: Global NGS-Based RNA-Sequencing Market by Application
    • 3.5.1: Expression Profiling Analysis
    • 3.5.2: Small RNA-Sequencing
    • 3.5.3: De Novo Transcriptome Assembly
    • 3.5.4: Variant Calling & Transcriptome Epigenetics
    • 3.5.5: Others
  • 3.6: Global NGS-Based RNA-Sequencing Market by End Use
    • 3.6.1: Research and Academia
    • 3.6.2: Hospitals and Clinics
    • 3.6.3: Pharmaceutical & Biotechnology
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global NGS-Based RNA-Sequencing Market by Region
  • 4.2: North American NGS-Based RNA-Sequencing Market
    • 4.2.1: North American NGS-Based RNA-Sequencing Market by Application: Expression Profiling Analysis, Small RNA-Sequencing, De Novo Transcriptome Assembly, Variant Calling & Transcriptome Epigenetics, and Others
    • 4.2.2: North American NGS-Based RNA-Sequencing Market by End Use: Research and Academia, Hospitals and Clinics, Pharmaceutical & Biotechnology, and Others
  • 4.3: European NGS-Based RNA-Sequencing Market
    • 4.3.1: European NGS-Based RNA-Sequencing Market by Application: Expression Profiling Analysis, Small RNA-Sequencing, De Novo Transcriptome Assembly, Variant Calling & Transcriptome Epigenetics, and Others
    • 4.3.2: European NGS-Based RNA-Sequencing Market by End Use: Research and Academia, Hospitals and Clinics, Pharmaceutical & Biotechnology, and Others
  • 4.4: APAC NGS-Based RNA-Sequencing Market
    • 4.4.1: APAC NGS-Based RNA-Sequencing Market by Application: Expression Profiling Analysis, Small RNA-Sequencing, De Novo Transcriptome Assembly, Variant Calling & Transcriptome Epigenetics, and Others
    • 4.4.2: APAC NGS-Based RNA-Sequencing Market by End Use: Research and Academia, Hospitals and Clinics, Pharmaceutical & Biotechnology, and Others
  • 4.5: ROW NGS-Based RNA-Sequencing Market
    • 4.5.1: ROW NGS-Based RNA-Sequencing Market by Application: Expression Profiling Analysis, Small RNA-Sequencing, De Novo Transcriptome Assembly, Variant Calling & Transcriptome Epigenetics, and Others
    • 4.5.2: ROW NGS-Based RNA-Sequencing Market by End Use: Research and Academia, Hospitals and Clinics, Pharmaceutical & Biotechnology, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by Product Type
    • 6.1.2: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by Technology
    • 6.1.3: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by Application
    • 6.1.4: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by End Use
    • 6.1.5: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by Region
  • 6.2: Emerging Trends in the Global NGS-Based RNA-Sequencing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global NGS-Based RNA-Sequencing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global NGS-Based RNA-Sequencing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Illumina
  • 7.2: Thermo Fischer Scientific
  • 7.3: Oxford Nanopore Technologies
  • 7.4: Agilent Technologies
  • 7.5: BGI